Literature DB >> 22124327

Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1.

Xiao-Xin Sun1, Kishore B Challagundla, Mu-Shui Dai.   

Abstract

The ubiquitin (Ub)-proteasome system plays a pivotal role in the regulation of p53 protein stability and activity. p53 is ubiquitinated and destabilized by MDM2 and several other Ub E3s, whereas it is deubiquitinated and stabilized by Ub-specific protease (USP)7 and USP10. Here we show that the ovarian tumour domain-containing Ub aldehyde-binding protein 1 (Otub1) is a novel p53 regulator. Otub1 directly suppresses MDM2-mediated p53 ubiquitination in cells and in vitro. Overexpression of Otub1 drastically stabilizes and activates p53, leading to apoptosis and marked inhibition of cell proliferation in a p53-dependent manner. These effects are independent of its catalytic activity but require residue Asp88. Mutation of Asp88 to Ala (Otub1(D88A)) abolishes activity of Otub1 to suppress p53 ubiquitination. Further, wild-type Otub1 and its catalytic mutant (Otub1(C91S)), but not Otub1(D88A), bind to the MDM2 cognate E2, UbcH5, and suppress its Ub-conjugating activity in vitro. Overexpression of Otub1(D88A) or ablation of endogenous Otub1 by siRNA markedly impaired p53 stabilization and activation in response to DNA damage. Together, these results reveal a novel function for Otub1 in regulating p53 stability and activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22124327      PMCID: PMC3273389          DOI: 10.1038/emboj.2011.434

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  Crystal structure of human otubain 2.

Authors:  Max H Nanao; Sergey O Tcherniuk; Jadwiga Chroboczek; Otto Dideberg; Andréa Dessen; Maxim Y Balakirev
Journal:  EMBO Rep       Date:  2004-07-16       Impact factor: 8.807

2.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

3.  Tumour suppression: disruption of HAUSP gene stabilizes p53.

Authors:  Jordan M Cummins; Carlo Rago; Manu Kohli; Kenneth W Kinzler; Christoph Lengauer; Bert Vogelstein
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

4.  Two isoforms of otubain 1 regulate T cell anergy via GRAIL.

Authors:  Luis Soares; Christine Seroogy; Heidi Skrenta; Niroshana Anandasabapathy; Patricia Lovelace; Chan D Chung; Edgar Engleman; C Garrison Fathman
Journal:  Nat Immunol       Date:  2003-12-07       Impact factor: 25.606

5.  The ubiquitin ligase COP1 is a critical negative regulator of p53.

Authors:  David Dornan; Ingrid Wertz; Harumi Shimizu; David Arnott; Gretchen D Frantz; Patrick Dowd; Karen O'Rourke; Hartmut Koeppen; Vishva M Dixit
Journal:  Nature       Date:  2004-04-21       Impact factor: 49.962

6.  Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.

Authors:  Mu-Shui Dai; Shelya X Zeng; Yetao Jin; Xiao-Xin Sun; Larry David; Hua Lu
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 7.  Cell cycle regulatory functions of the human oncoprotein MDM2.

Authors:  Swati Palit Deb
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

8.  Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5.

Authors:  Mu-Shui Dai; Hua Lu
Journal:  J Biol Chem       Date:  2004-08-11       Impact factor: 5.157

9.  MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC).

Authors:  Dorota Dworakowska; Ewa Jassem; Jacek Jassem; Brigitte Peters; Rafał Dziadziuszko; Maciej Zylicz; Joanna Jakóbkiewicz-Banecka; Grazyna Kobierska-Gulida; Amelia Szymanowska; Jan Skokowski; Albert Roessner; Regine Schneider-Stock
Journal:  Lung Cancer       Date:  2004-03       Impact factor: 5.705

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  90 in total

Review 1.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

2.  Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation.

Authors:  Yu-Che Cheng; Sheau-Yann Shieh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

Review 3.  Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.

Authors:  Matthew Saldana; Kacey VanderVorst; Anastasia L Berg; Hyun Lee; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2019-01-01       Impact factor: 5.678

4.  Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.

Authors:  Yuhuang Li; Xiao-Xin Sun; Johannes Elferich; Ujwal Shinde; Larry L David; Mu-Shui Dai
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

5.  The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.

Authors:  Xiao-Xin Sun; Xia He; Li Yin; Masayuki Komada; Rosalie C Sears; Mu-Shui Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-09       Impact factor: 11.205

6.  The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Authors:  Johanna Bialas; Annika N Boehm; Nicola Catone; Annette Aichem; Marcus Groettrup
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

7.  OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.

Authors:  Honghong Zhou; Yongshuo Liu; Rui Zhu; Fang Ding; Xiufeng Cao; Dongxin Lin; Zhihua Liu
Journal:  Oncogene       Date:  2018-03-21       Impact factor: 9.867

8.  The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11.

Authors:  Tong Liu; Le Jiang; Omid Tavana; Wei Gu
Journal:  Cancer Res       Date:  2019-02-01       Impact factor: 12.701

9.  OTUB1 modulates c-IAP1 stability to regulate signalling pathways.

Authors:  Tatiana Goncharov; Kyle Niessen; Maria Cristina de Almagro; Anita Izrael-Tomasevic; Anna V Fedorova; Eugene Varfolomeev; David Arnott; Kurt Deshayes; Donald S Kirkpatrick; Domagoj Vucic
Journal:  EMBO J       Date:  2013-03-22       Impact factor: 11.598

Review 10.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.